ACETYLCYSTEINE SOLU

The Defense Logistics Agency (DLA) awarded a delivery order under master contract SPE2DX25D8022 to Cardinal Health, Inc. (CAGE 00E55) for the procurement of Acetylcysteine Solution, identified by NSN 6505007822688 and project number 7017500905. The contract, issued as a standalone delivery order with solicitation number SPE2D926F7338, carries a total value of $42.38 for two units at a unit price of $21.19. Delivery is scheduled for July 14, 2026, to FPO AP 96671, US, aboard USNS LOYAL T AGOS 22, Unit 100464 Box 1, with FOB Destination terms placing transportation costs and risk of loss on the contractor. The product must conform to DLA internal procedures C19 and C20, and all packaging and documentation must be clearly marked with the CAGE code, NSN, project number, required delivery date, and transportation control number N218686195S604 to ensure compatibility with automated logistics tracking systems. No specific packaging standards, barcoding specifications, or MIL-STD references are mandated, though marking practices align with common DoD conventions. Inspection and acceptance occur at the destination point by government representatives, with compliance determined solely by adherence to contractual specifications. Cardinal Health, Inc. is certified as a small business in SAM, triggering FAR 52.212-3 and FAR 52.219-1 requirements, though no other socioeconomic or affirmative certifications apply. Payment is processed by the Defense Finance and Accounting Service in Columbus, Ohio, using the accounting code BX: 97X4930 5CBX 001 2620 S33189. The contracting officer is Lisa Quinn, with Michelle Pampel serving as the local administrator, and no formal COR or COTR is designated. The delivery order is issued under an IDIQ framework, with no options, modifications, or extended performance periods indicated, and all terms reflect a streamlined, one-time replenishment transaction governed by standard DLA commercial item protocols.